Connect with us

General Health

Transplant Diagnostics Market on target to reach $1.03 Billion by 2022

Transplant Diagnostics Market by Molecular and Non-Molecular Assay Technology (Serological assay, Mixed Lymphocyte Culture, PCR Based, Sequencing Based), End-User (Hospitals and transplant centers, Research laboratories and academic institutes, Commercial Service Providers) – Global Opportunity Analysis and Industry Forecast, 2014 – 2022

Published

on

Transplant Diagnostics Market
Press Release

Transplant Diagnostics Market Outlook 2014-2022:

Global Transplant Diagnostics Market is expected to grow $1.03 billion by 2022, registering a CAGR of 10% during the period 2016-2022. The serological assay technology is the most preferred, which accounted for about half of the market share globally, in 2015.

Major players added in this Transplant Diagnostics Market report are Immucor, Inc. (TGI Capital), Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc. F. Hoffmann-la Roche AG, Illumina Inc., Abbott Laboratories, Sigma-Aldrich Corporation, and others.

The major players have adopted product approval & launch as their key strategy to cater to the volatile industry needs and merger & acquisition to strengthen their brand value, product portfolio, and market position. Development of novel products incorporated with innovative technology supplemented with aggressive acquisition activity are the instrumental strategies adopted by leading players.

Download Sample Copy of this Report at: https://www.alliedmarketresearch.com/request-sample/1135

The reagents & consumables segment is projected to remain dominant throughout the forecast period. North America held the leading market position in 2015, and is expected to maintain this trend.

Increase in incidence of organ failure owing to growing cases of chronic diseases, rise in ageing population, and increase in focus on R&D is expected to propel the growth of the global transplant diagnostics market. Chronic diseases can lead to organ failure in patients, which could be a significant target audience for transplant diagnostics procedures. However, difficulties in human leukocyte antigen (HLA) sequencing and increasing worldwide organ shortage can hamper the market growth.

The reagents & consumables segment accounted for the maximum revenue generation in 2015, owing to the increased number of diagnostics procedures pre and post organ transplantation. The instruments & equipment segment is projected to grow at a CAGR of 9.1% and reach $76.3 million by 2022. Both the technologies, namely non molecular assay and molecular assay hold significant position in the global transplant diagnostics market. However, molecular assay technology segment is projected to grow at the highest CAGR of 12.3%, due to highly accurate results provided by the modern molecular assay technology.

With rise in number of kidney transplants, the segment is set to report a high revenue in the future, with a CAGR of 9.8%, owing to increased incidence of renal failure worldwide. Liver and heart transplants are estimated to report a strong growth rate during the forecast duration, due to increased awareness for organ donations and increase in incidence of liver and heart failure.

First time buyer? Check offers and discount on this report: https://www.alliedmarketresearch.com/purchase-enquiry/1135

Transplant Diagnostics Market Key Findings:

  • In the year 2015, reagents & consumables generated the highest revenue, and is projected to grow at a CAGR of 10%.
  • Software segment is projected to grow at the highest CAGR of 13.4%.
  • Kidney transplants is the major surgical procedure that requires transplant diagnostics.
  • The molecular assay segment is expected grow at a CAGR of 12.3%.
  • U.S. is the leading country and is projected to grow at a CAGR 9.9%.
  • In Asia-Pacific, South Korea led in 2015 and is expected to grow at a CAGR of 10.4%.

North America accounted for a major market share in 2015, with maximum revenue contribution from the U.S., due to large number of transplant procedures of kidney, liver, lung, heart, and pancreas. Adoption of latest technology and increase in awareness regarding organ transplantation in the U.S. have boosted the North American transplant diagnostics market. The Asia-Pacific region offers lucrative opportunities for transplant diagnostics market players to expand their market presence. This region has the highest geriatric population, and the scenario is estimated to continue; further felling market growth for transplant diagnostics.

 

Read More @ https://www.prnewswire.com/news-releases/transplant-diagnostics-market-is-expected-to-reach-1031-million-globally-by-2022—allied-market-research-601475975.html

This post was originally published on Health News Office

General Health

Global Medical Practice Management (PMS) Market by Manufacturers, Countries, Type, and Application, Forecast to 2024

Published

on

Press Release

The healthcare industry is a gathering and integration of divisions within the economic system that provides goods and services to treat patients with healing, preventive, and palliative care. The modern healthcare industry is divided into many divisions and depends on the associative teams of trained specialists and professionals to meet the health needs of Individuals and cultures.

In Detail, this report presents the global market share (sales and revenue) of key companies in Medical Practice Management (PMS).

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Practice Management (PMS) market by product type, application, key manufacturers and key regions and countries.

This report focuses on the Medical Practice Management (PMS) in the global market, especially in North America, Europe and Asia-Pacific, South America, Middle East, and Africa. This report categorizes the market based on manufacturers, regions, type, and applications.

For Sample Click On: https://www.marketresearchnest.com/report/requestsample/753824

Companies Covered As Per (Sales, Price, Revenue, Volume, Gross Margin, and Market Share)

  • AthenaHealth
  • Epic Systems
  • McKesson Corporation
  • Allscripts
  • eClinicalWorks
  • Virence Health
  • AdvancedMD
  • Henry Schein
  • Cerner Corporation
  • Greenway Health
  • CollaborateMD
  • TotalMD
  • MPN Software Systems
  • Bestosys Solutions
  • CareCloud
  • NexTech Systems
  • Aprima Medical Software
  • Insta Health Solutions
  • ChartPerfect
  • NextGen Healthcare
  • Adroit Infosystems

Market Segment by Regions, regional analysis covers

  • North America (the United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America (Brazil, Argentina, Colombia, etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Types, covers:

  • Web-based
  • On-premise
  • Cloud-based

Market Segment by Applications, can be divided into:

  • Hospitals
  • Diagnostic Laboratories
  • Pharmacies
  • Other

For More Information: https://www.marketresearchnest.com/Global-Medical-Practice-Management-PMS-Market-2019-by-Company-Regions-Type-and-Application-Forecast-to-2024.html

We Also Provide Customized Report Based On Specific Client Requirement (Contact Our Sales Team)

[email protected]

This post was originally published on Health News Office

Continue Reading

General Health

Global ED Treatment Market by Manufacturers, Countries, Type and Application, Forecast to 2024

Published

on

Press Release

The healthcare industry is a gathering and integration of divisions within the economic system that provides goods and services to treat patients with healing, preventive, and palliative care. The modern healthcare industry is divided into many divisions and depends on the associative teams of trained specialists and professionals to meet the health needs of Individuals and cultures.

In Detail, this report presents the global market share (sales and revenue) of key companies in ED Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of ED Treatment market by product type, application, key manufacturers and key regions and countries.

This report focuses on the ED Treatment in the global market, especially in North America, Europe and Asia-Pacific, South America, Middle East, and Africa. This report categorizes the market based on manufacturers, regions, type, and applications.

For Sample Click On: https://www.marketresearchnest.com/report/requestsample/753822

Companies Covered As Per (Sales, Price, Revenue, Volume, Gross Margin, and Market Share)

  • Eli Lilly
  • Metuchen Pharma
  • BaiYunShan General Factory
  • Pfizer
  • Dong-A ST
  • Bayer
  • Teva Pharma
  • K. Chemicals
  • Seoul Pharma

Market Segment by Regions, regional analysis covers

  • North America (the United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America (Brazil, Argentina, Colombia, etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Types, covers:

  • Sildenafil
  • Tadalafil
  • Others

Market Segment by Applications, can be divided into:

  • Hospitals
  • Drugstores
  • Other

For More Information: https://www.marketresearchnest.com/Global-ED-Treatment-Market-2019-by-Manufacturers-Regions-Type-and-Application-Forecast-to-2024.html

We Also Provide Customized Report Based On Specific Client Requirement (Contact Our Sales Team)

[email protected]

This post was originally published on Health News Office

Continue Reading

General Health

Global Antihistamines Travel Sickness Drugs Industry Revenue, Sales and Growth Rate 2019-2024

Published

on

Press Release

The healthcare industry is a gathering and integration of divisions within the economic system that provides goods and services to treat patients with healing, preventive, and palliative care. The modern healthcare industry is divided into many divisions and depends on the associative teams of trained specialists and professionals to meet the health needs of Individuals and cultures.

In Detail, this report presents the global market share (sales and revenue) of key companies in Antihistamines Travel Sickness Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Antihistamines Travel Sickness Drugs market by product type, application, key manufacturers and key regions and countries.

This report focuses on the Antihistamines Travel Sickness Drugs in the global market, especially in North America, Europe and Asia-Pacific, South America, Middle East, and Africa. This report categorizes the market based on manufacturers, regions, type, and applications.

For Sample Click On: https://www.marketresearchnest.com/report/requestsample/753820

Companies Covered As Per (Sales, Price, Revenue, Volume, Gross Margin, and Market Share)

  • Prestige Brands
  • Sandoz
  • WellSpring Pharmaceutical Corporation
  • Caleb Pharmaceuticals
  • Mylan
  • Myungmoon Pharm
  • Pfizer

Market Segment by Regions, regional analysis covers

  • North America (the United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, and Italy)
  • Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
  • South America (Brazil, Argentina, Colombia, etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Types, covers:

  • Adults
  • Children

Market Segment by Applications, can be divided into:

  • Hospitals
  • Drugstores
  • Other

For More Information: https://www.marketresearchnest.com/Global-Antihistamines-Travel-Sickness-Drugs-Market-2019-by-Manufacturers-Regions-Type-and-Application-Forecast-to-2024.html

We Also Provide Customized Report Based On Specific Client Requirement (Contact Our Sales Team)

[email protected]

This post was originally published on Health News Office

Continue Reading

Trending